First-class academic journals have important influencing factors in the academic community, and their profitability depends on the support of large-scale magazine subscriptions and various academic research funds.

There will be no impact factors for third-rate academic journals, and no authoritative papers. You can only rely on publishing papers with low academic value to make a living by the author's bad money.

"Biosciences and Medical Technology" has been doing this kind of bad money for the past decade.

However, existence is reasonable. Although "Bioscience and Medical Technology" is very bad, it also helps many students who need to evaluate their professional titles and get a diploma, so that they can achieve their small goals if they are legal and compliant but cannot write in-depth papers.

However, in recent days, "Bioscience and Medical Technology" has changed its way of life.

Many universities, hospitals, and research institutions have purchased "Biosciences and Medical Technology". Although they only ordered the issue of the paper published by Origin Technology, this is also a very good start.

In academia, "Biosciences and Medical Technology" (hereinafter referred to as "Bioscience") is called "Seeing Beads of Knowing the Wisdom"!

When major academic weekly magazines such as "Nature" and "Cell" in the West and "Bioscience" rejected papers on Origin Science and Technology, "Bio Doctor" was published. What is this not a wise eye to recognize the beads?

Editor-in-chief Zhang Feng told everyone how he discovered the papers on Origin Technology and how he was so proud of it, and decided to publish the papers.

The actual situation was that Zhang Feng knew that symbiotic protein was popular in treating respiratory diseases and realized that this paper was published here.

It's different from Zhang Feng's show.

The headquarters of the magazine Biological Sciences found paper review experts (many are professionals from universities and research institutions) to reexamine why this paper was not published.

Finally, the experts unanimously concluded that if time is redoubled back, the paper will still be reviewed, but the reason is still too advanced, just like a rootless duckweed.

Experts discussed:

"There is no point in discussing this issue now, because the clinical experiment of Huaxi and Zhiyuan Technology was successful."

"I actually really want to go to Rongcheng to see those patients who have recovered after treatment, and use symbiotic green leaf protein to replace the lungs for breathing. I can't even think about it."

This is what everyone said in the meeting.

In fact, Biological Science is very regretful. If the original thinking was a little more active and published a paper on Origin Science, it might have established itself as the number one academic journal in China.

An expert in Biological Science commented: "Since clinically proves the authenticity of the paper, this paper has certainly had a historical status in the medical and biological worlds. Unfortunately, we missed this opportunity."

Some experts also said: "I have contacted Huaxi Hospital. Next week, I will participate in the treatment of symbiotic proteins for patients. I also need to see how the links we were puzzled when reviewing the paper."

The biomedical community in Xiaguo is actively studying the papers and related experiments on the symbiotic photosynthetic chlorophyllium protein of Origin Technology that replaces the lungs to transport oxygen to the body. This incident has also attracted the attention of European and American media.

The New York Times, BBC and other Western media stationed in Chengdu reported the news and called it an "impossible" experiment to verify it from the Western academic community.

The Western medical and biological academic circles did not care about the experiments of Origin Technology, but under the media's questioning, they have been paying attention to the trends of Huaxi Hospital and technology.

If the clinical treatment of Origin Technology is really successful, it will definitely change the history of human biomedical science, and Western academics suspect that Origin Technology academic fraud is false.

After all, symbiotic protein technology is unheard of. How did Xia Guoren, who had poor high-end medical technology solve the problems in the history of human medicine?

This not only solves the problem, but also creates a new biomedical direction for the future of mankind!

How is this possible!

The most leading country in the world in medicine is the United States. The United States has never thought of symbiotic proteins replacing lung breathing. How could an unknown Xiaguo company create a new biology discipline?

Why is the West the center of the world? Because the center of technology is in the West.

The most important thing for all human science and technology centers is basic technology.

These basic technologies include mathematics, physics, chemistry, biomedicine, etc.

In basic science, the West is in an absolute leading position, and basic science and technology are absolutely leading, which means leading the right to speak.

The monopoly of basic technology also means the monopoly of wealth.

Two very typical examples.

First, as an example, the world's top medical institutions are in the United States, and the best pharmaceutical companies are also in the United States.

Most of the anti-cancer drugs in Xia Kingdom are imported from the United States or Europe, and terminally ill patients with conditions also hope to go to the United States for treatment.

Those targeted drugs that can be paid for tens of thousands or more at their own expenses at any time are from Western pharmaceutical companies.

Because Xia Guo enterprises cannot produce them, and their intellectual property rights are firmly grasped in the hands of Westerners, they monopolize and are the only ones, and it is understandable to sell you at a high price (the pharmaceutical companies that produce anti-cancer drugs in Yindian only imitate production processes and do not care about intellectual property rights, and do not develop and master the most fundamental core technology themselves).

Second, the core chip technologies based on new physical materials and computer science are also in the West.

Xia Kingdom spends trillions of dollars on purchasing chips every year, and the cost of importing chips far exceeds the cost of importing oil.

Most of the richest private enterprises in Xiaguo, including BTA, do epidermis Internet and software, and almost does not involve chips because there is no technology or talent.

Because Xia Guo's chip technology is subject to Western technical barriers, it is two to three generations different from the most advanced Western technologies, which is more than ten or twenty years.

Based on these preconditions, when Origin Technology launches some subversive biomedical technology, the first reaction of the Western academic community is suspicion!

In an interview with the New York Times, several of the most famous professors of biomedical science at Stanford University in the United States refuted the research results of Origin Technology and called it impossible.

Middle of Stanford University is an expert in respiratory medicine. Ositinib, one of the world's most advanced lung cancer targeted drugs, was developed by Middle's team and AstraZeneca, the UK.

Ositinib is priced at about 16,000 yuan per box in China, and patients need to take one box in a month. This price is something that most families cannot afford.

The monopoly of life-saving drugs allowed Middle's team to get generous rewards from AstraZeneca.

Middle told reporters: "The treatment method of Origin Technology is absurd and unreasonable for Middle. It is impossible to achieve. I do not evaluate the academic environment of Xia Kingdom, but I heard that "Nature" also rejected the paper of Xia Kingdom, which says everything."
Chapter completed!